{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:57:40Z","timestamp":1785513460140,"version":"3.56.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The link between female reproductive factors and pancreatic cancer risk is unclear. This study examined these associations in a large prospective cohort and explored potential modification by genetic susceptibility. We analyzed data from 196 563 women in the UK Biobank using multivariable Cox proportional hazards models. Stratified analyses were performed by age, smoking status, BMI, and genetic susceptibility (polygenic risk score, dichotomized as low\/high), with multiplicative interaction terms testing effect modification. Sensitivity analyses assessed robustness. Over a median 13.68-year follow-up, 624 pancreatic cancer cases occurred. Menopause at ages 47\u201349 [versus 50\u201352, hazard ratio: 0.75, 95% confidenc interval (CI): 0.56\u20130.99] and first live birth at ages 31\u201335 (versus 26\u201330, hazard ratio: 0.50, 95% CI: 0.31\u20130.82) were associated with lower risk, whereas prior hormone replacement therapy (HRT) use (versus never, hazard ratio: 1.26, 95% CI: 1.07\u20131.49) was linked to higher risk. Results were consistent in sensitivity analyses. Genetic susceptibility significantly modified associations for first live birth at ages 31\u201335 (stronger protection in high genetic risk), three live births (stronger protection in low genetic risk), and bilateral oophorectomy (increased risk in low genetic risk) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 for interaction). These findings indicate that age at menopause, age at first live birth, and HRT use are associated with pancreatic cancer risk, and that certain reproductive factors \u2013 age at first live birth, parity, and bilateral oophorectomy \u2013 interact with genetic susceptibility. This provides further evidence for the role of reproductive factors in pancreatic cancer etiology.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cej.0000000000000987","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:00:08Z","timestamp":1756742408000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association between female reproductive factors and new-onset pancreatic cancer risk: a prospective cohort study"],"prefix":"10.1097","volume":"35","author":[{"given":"Shuai","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing"},{"name":"Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing"},{"name":"Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxing","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Pancreatic and Gastric Surgery, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing"},{"name":"Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"R1-20260731","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/CLEP.S268556","article-title":"Reproductive factors, use of exogenous hormones, and pancreatic cancer incidence: the Norwegian women and cancer study.","volume":"13","author":"Alvarez","year":"2021","journal-title":"Clin Epidemiol"},{"key":"R2-20260731","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/ijc.31302","article-title":"Hormonal factors and pancreatic cancer risk in women: the Malm\u00f6 Diet and Cancer Study.","volume":"143","author":"Andersson","year":"2018","journal-title":"Int J Cancer"},{"key":"R3-20260731","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-005-0096-0","article-title":"The effect of conjugated equine oestrogen on diabetes incidence: the Women\u2019s Health Initiative randomised trial.","volume":"49","author":"Bonds","year":"2006","journal-title":"Diabetologia"},{"key":"R4-20260731","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-024-03574-x","article-title":"Cancer incidence (2000-2020) among individuals under 35: an emerging sex disparity in oncology.","volume":"22","author":"Cavazzani","year":"2024","journal-title":"BMC Med"},{"key":"R5-20260731","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10680-016-9378-0","article-title":"Ready, willing, and able: contraceptive use patterns across Europe.","volume":"32","author":"Dereuddre","year":"2016","journal-title":"Eur J Popul"},{"key":"R6-20260731","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2021.09.022","article-title":"Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence.","volume":"162","author":"Dreyer","year":"2022","journal-title":"Gastroenterology"},{"key":"R7-20260731","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/ijc.27875","article-title":"Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.","volume":"132","author":"Duell","year":"2013","journal-title":"Int J Cancer"},{"key":"R8-20260731","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ijc.2910620104","article-title":"Menstrual and reproductive factors and pancreatic cancer risk in women.","volume":"62","author":"Fernandez","year":"1995","journal-title":"Int J Cancer"},{"key":"R9-20260731","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/jnci\/djac069","article-title":"Pancreatic ductal carcinoma risk associated with hereditary cancer-risk genes.","volume":"114","author":"Gardiner","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"R11-20260731","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjc.6604095","article-title":"Reproductive factors and pancreatic cancer risk: a Norwegian cohort study.","volume":"98","author":"Heuch","year":"2008","journal-title":"Br J Cancer"},{"key":"R12-20260731","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women.","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"R13-20260731","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19960516)66:4<432::AID-IJC4>3.0.CO;2-X","article-title":"Anthropometric and reproductive factors and the risk of pancreatic cancer: a case-control study in Shanghai, China.","volume":"66","author":"Ji","year":"1996","journal-title":"Int J Cancer"},{"key":"R14-20260731","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.envint.2018.04.020","article-title":"Does exposure to PM(10) decrease age at menarche?","volume":"117","author":"Jung","year":"2018","journal-title":"Environ Int"},{"key":"R15-20260731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canep.2017.05.002","article-title":"Reproductive factors, exogenous hormone use, and risk of pancreatic cancer in postmenopausal women.","volume":"49","author":"Kabat","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"R16-20260731","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the heart and estrogen\/progestin replacement study. A randomized, double-blind, placebo-controlled trial.","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"R17-20260731","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1097-0215(19980717)77:2<224::AID-IJC10>3.0.CO;2-B","article-title":"Parity and the risk of pancreatic cancer: a nested case-control study.","volume":"77","author":"Karlson","year":"1998","journal-title":"Int J Cancer"},{"key":"R18-20260731","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/cancers17142275","article-title":"Sex disparities and female reproductive and hormonal factors associated with risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.","volume":"17","author":"Katzke","year":"2025","journal-title":"Cancers"},{"key":"R19-20260731","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1093\/aje\/kwt154","article-title":"Reproductive factors, exogenous hormones, and pancreatic cancer risk in the CTS.","volume":"178","author":"Lee","year":"2013","journal-title":"Am J Epidemiol"},{"key":"R20-20260731","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MPA.0b013e31820bf986","article-title":"Reproductive and hormonal factors and pancreatic cancer risk in women.","volume":"40","author":"Lucenteforte","year":"2011","journal-title":"Pancreas"},{"key":"R21-20260731","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ije\/dyu240","article-title":"Risk factors for pancreatic cancer: a summary review of meta-analytical studies.","volume":"44","author":"Maisonneuve","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R22-20260731","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women\u2019s Health Initiative Hormone Trial.","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"R23-20260731","doi-asserted-by":"crossref","first-page":"146","DOI":"10.15171\/mejdd.2017.65","article-title":"Menstrual and reproductive factors and risk of pancreatic cancer in women.","volume":"9","author":"Masoudi","year":"2017","journal-title":"Middle East J Dig Dis"},{"key":"R24-20260731","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/cncr.21166","article-title":"Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.","volume":"104","author":"McWilliams","year":"2005","journal-title":"Cancer"},{"key":"R25-20260731","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcmgh.2020.04.016","article-title":"Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma.","volume":"10","author":"Natale","year":"2020","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R26-20260731","doi-asserted-by":"crossref","first-page":"114226","DOI":"10.1016\/j.ejca.2024.114226","article-title":"Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients.","volume":"208","author":"Orsi","year":"2024","journal-title":"Eur J Cancer"},{"key":"R27-20260731","doi-asserted-by":"crossref","first-page":"18100","DOI":"10.1038\/s41598-022-22973-9","article-title":"Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.","volume":"12","author":"Peduzzi","year":"2022","journal-title":"Sci Rep"},{"key":"R28-20260731","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/2050640617702060","article-title":"Menopausal hormone therapy and pancreatic cancer risk in women: a population-based matched cohort study.","volume":"5","author":"Sadr-Azodi","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"R29-20260731","first-page":"433","article-title":"Parity, reproductive factors, and the risk of pancreatic cancer in women.","volume":"12","author":"Skinner","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R30-20260731","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1158\/1055-9965.EPI-08-1134","article-title":"Reproductive history and pancreatic cancer incidence and mortality in a cohort of postmenopausal women.","volume":"18","author":"Stevens","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R31-20260731","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1158\/0008-5472.CAN-18-3064","article-title":"Prolactin promotes fibrosis and pancreatic cancer progression.","volume":"79","author":"Tandon","year":"2019","journal-title":"Cancer Res"},{"key":"R32-20260731","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/MD.0000000000000177","article-title":"Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies.","volume":"94","author":"Tang","year":"2015","journal-title":"Medicine (Baltim)"},{"key":"R33-20260731","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/CEJ.0000000000000358","article-title":"Female reproductive factors, exogenous hormone use, and pancreatic cancer risk: the Japan Public Health Center-based prospective study.","volume":"26","author":"Teng","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"R34-20260731","first-page":"1035","article-title":"Parity, other reproductive factors, and risk of pancreatic cancer mortality in a large cohort of U.S. women (United States).","volume":"16","author":"Teras","year":"2005","journal-title":"Cancer Causes Control"},{"key":"R35-20260731","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.annepidem.2008.11.003","article-title":"Reproductive factors and risk of pancreatic cancer in women: a review of the literature.","volume":"19","author":"Wahi","year":"2009","journal-title":"Ann Epidemiol"},{"key":"R36-20260731","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jcmgh.2021.04.005","article-title":"Sex differences in the exocrine pancreas and associated diseases.","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R37-20260731","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.19.01907","article-title":"Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families.","volume":"38","author":"Yang","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000000987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:02:50Z","timestamp":1785510170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CEJ.0000000000000987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000987","relation":{},"ISSN":["0959-8278","1473-5709"],"issn-type":[{"value":"0959-8278","type":"print"},{"value":"1473-5709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"2025-06-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}